Clinical trial

A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in…

NCT00208390 · DePuy International, Industry · Terminated

Key facts

NCT number NCT00208390
Title A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement
Official title Prospective, Uncontrolled, Multi-Centre, Post-Marketing Surveillance Study to Evaluate the Long-Term Performance of Summit Tapered Hip in Cementless Total Hip Arthroplasty
Lead sponsor DePuy International, Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Rheumatoid Arthritis, Osteoarthritis, Post-traumatic Arthritis, Collagen Disorders, Avascular Necrosis, Traumatic Femoral Fractures, Nonunion of Femoral Fractures, Congenital Hip Dysplasia, Slipped Capital Femoral Epiphysis
Intervention type Device
Interventions Summit Tapered Hip System
Enrollment 275
Start date Feb 1, 2003
Primary completion May 1, 2012
Completion May 1, 2012
First posted Sep 21, 2005
Last update posted Aug 4, 2016
Countries China, Hong Kong, Italy, New Zealand, South Korea

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies